Oleoylethanolamide enhances microglial Aβ clearance and improves cognitive function in 5xFAD AD mice by promoting TFEB lysosomal function in a PPARα-dependent manner, independent of mTORC1 125. Here, TFEB is linked to Alzheimer disease.